| Dr Karine Thevenin, DO | |
|
141 E Emaus Ave, Allentown, PA 18103-5824 | |
| (610) 791-5930 | |
| (610) 791-2157 |
| Full Name | Dr Karine Thevenin |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 141 E Emaus Ave, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548405913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS014601 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | 25MR1155400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
| Patient First Maryland Physicians Group, P.c.. | 9335391978 | 45 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
Pancreatitis is a condition in which the pancreas becomes inflamed, causing severe abdominal pain. It is often triggered by alcohol consumption which causes digestive enzymes to digest part of the pancreas.
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
Pancreatitis is a condition in which the pancreas becomes inflamed, causing severe abdominal pain. It is often triggered by alcohol consumption which causes digestive enzymes to digest part of the pancreas.
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
Pancreatitis is a condition in which the pancreas becomes inflamed, causing severe abdominal pain. It is often triggered by alcohol consumption which causes digestive enzymes to digest part of the pancreas.
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
Pancreatitis is a condition in which the pancreas becomes inflamed, causing severe abdominal pain. It is often triggered by alcohol consumption which causes digestive enzymes to digest part of the pancreas.
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karine Thevenin, DO Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Dr Karine Thevenin, DO 141 E Emaus Ave, Allentown, PA 18103-5824 Ph: (610) 791-5930 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
Pancreatitis is a condition in which the pancreas becomes inflamed, causing severe abdominal pain. It is often triggered by alcohol consumption which causes digestive enzymes to digest part of the pancreas.
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.
› Verified 4 days ago
Dr. Xander Arwand, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 110, Allentown, PA 18103 Phone: 610-402-8900 Fax: 610-402-5656 | |
John E Connelly, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 N 17th St, Suite # 108, Allentown, PA 18104 Phone: 610-434-4760 Fax: 610-820-9122 | |
Dr. Ann Marie Lam, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1251 S Cedar Crest Blvd, Suite 102 A, Allentown, PA 18103 Phone: 610-402-3940 Fax: 610-102-3950 | |
Leyland Robinson, Family Medicine Medicare: Medicare Enrolled Practice Location: 3435 Winchester Rd Ste 201, Allentown, PA 18104 Phone: 610-402-0100 | |
Dr. Joseph Thomas Termini, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 942 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-433-0404 | |
Madhavi Capoccia, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 115, Allentown, PA 18104 Phone: 610-395-0307 Fax: 610-395-0950 | |
Pavel Enrique Terreros, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1447 W Hamilton St, Allentown, PA 18102 Phone: 610-434-4445 |